http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2270209-C1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L89-00
filingDate 2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e0162cf8e2ff5b87b6b514431ddd151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbca358f3f0a718005550defc7eaee3b
publicationDate 2006-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2270209-C1
titleOfInvention Method of manufacturing porous material from fibroin/chitosan mixture
abstract FIELD: pharmaceutical industry, dosage form preparation methods. n SUBSTANCE: invention relates to manufacturing articles by way of recovering natural polymers fibroin and chitosan from solutions, which substances can be used as carriers for administering drugs (capsules, fibers, variously shaped artificial substitutes). Fibroin solution dialyzed against lithium bromide aqueous solution is mixed with chitosan solution, whereupon solvent is evaporated and recovered fibroin and chitosan are dried and dissolved in hexafluoroisopropanol at pH 4.5-5.5 and 25-50°C to concentration between 1 and 15 wt % at fibroin-to-chitosan ratio between 9:1 and 1:4. Fibroin is preliminarily dissolved in 6-10 M lithium bromide aqueous solution and, after dialysis, dried at temperature not higher than 40°C. Porous material recovered after evaporation of solvent is treated with methanol for at least 5 min at liquor ratio between 1:1 and 1:20. n EFFECT: improved drug release control due to specified degree of swelling through fibroin/chitosan material pores and increased integrity of material to 70% resulting in several times slowed down degradation of porous material in body. n 4 cl, 1 dwg, 2 tbl, 16 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011017930-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2623862-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112280058-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112280058-B
priorityDate 2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13529
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447612385
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID7091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4764
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID7091

Total number of triples: 30.